Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05MLX
|
|||
| Former ID |
DIB008655
|
|||
| Drug Name |
ONYX-411
|
|||
| Synonyms |
Anticancer adenoviruses, Onyx; Armed virus therapy, Onyx; ONYX-201; ONYX-203; ONYX-443; ONYX-740; ONYX-741; ONYX-742; ONYX-838; RB virus, Onyx; E1A CR1-and CR2-deleted adenoviruses, ONYX
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Terminated | [1] | |
| Company |
Onyx Pharmaceuticals Inc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800011303) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.